[Pembrolizumab (Keytruda®) associated ocular hypotony].
Dierse S; Al-Naweiseh S; Esser E; Englmaier V; Eter N; Clemens CR
Research article (journal) | Peer reviewedDetails about the publication
Journal: Die Ophthalmologie (Ophthalmologie)
Volume: 120
Issue: 10
Page range: 1042-1044
Status: Published
Release year: 2023 (30/10/2023)
Language in which the publication is written: German
Keywords: Pembrolizumab; Immuncheckpointinhibitoren; Hypotonia bulbi
Authors from the University of Münster
| Al-Nawaiseh, Sami | Clinic for Ophthalmology |
| Clemens, Christoph | Clinic for Ophthalmology |
| Dierse, Sebastian | Clinic for Ophthalmology |
| Englmaier, Verena Anna | Clinic for Ophthalmology |
| Esser, Eliane Luisa | Clinic for Ophthalmology |
| Eter, Nicole | Clinic for Ophthalmology |